image: The University of North Carolina Lineberger Comprehensive Cancer Center’s 45th annual scientific symposium will feature 14 talks addressing the central theme: The Biology of Aggressive Cancers and Tumor-Stroma Interactions.” view more
Credit: UNC Lineberger Comprehensive Cancer Center
The University of North Carolina Lineberger Comprehensive Cancer Center’s 45th annual scientific symposium on April 18-19, 2022, will feature 14 talks addressing the central theme: The biology of aggressive cancers and tumor-stroma interactions.” The scientific meeting is free and it will take place in Chapel Hill, NC. It also will be streamed online for those wanting to attend virtually. More information is available online, https://unclineberger.org/symposium/, and registration is required, https://unclineberger.org/symposium/registration/
Schedule
Monday, April 18 from 9 a.m. – 5 p.m. ET
Tuesday, April 19 from 9 a.m. – 1 p.m. ET
Speakers
Paula Bos, PhD, Virginia Commonwealth University: “Mechanistic Dissection of Treg Cell Contribution to Breast Cancer Progression”
Edna Cukierman, PhD, Fox Chase Cancer Center: “NET(NetG1/NGL1) Control of the Pancreatic Cancer Microenvironment”
Ron DePinho, MD, MD Anderson Cancer Center: “Genetics and Biology of the Tumor Microenvironment”
Channing Der, PhD, UNC Lineberger Comprehensive Cancer Center: “Targeting KRAS for Cancer Treatment: the Last Dance?”
Christine Iacobuzio-Donahaue, MD, PhD, Memorial Sloan Kettering Cancer Center: “Pancreatic Cancer Genetics: An Evolving Story”
Elizabeth Jaffee, MD, Sidney Kimmel Comprehensive Cancer Center: “Pancreatic Cancer is Primed to Become an Immunologic Disease”
Rosandra Kaplan, MD, National Cancer Institute: “Learning from the Metastatic Niche – Empowering the Tumor Microenvironment to Limit Metastatic Progression”
Kamila Naxerova, PhD, Massachusetts General Hospital: “On the Evolutionary History of Metastatic Cancer”
Chad Pecot, MD, UNC Lineberger Comprehensive Cancer Center: “Biologic and Structural Insights of How Circle RNAs Promote Metastasis”
Avery Posey, PhD, University of Pennsylvania: “Exploiting Truncated O-glycosylation in Tumors for Immunotherapy”
Mara Sherman, PhD, Oregon Health & Science University: “Mechanisms and Consequences of Pancreatic Cancer Stromal Evolution.”
David Tuveson, MD, PhD, Cold Spring Harbor Laboratory: “Pancreatic Cancer Progression and Therapy”
Jen Jen Yeh, MD, UNC Lineberger Comprehensive Cancer Center: “Precision Oncology Approaches in Pancreatic Cancer”
Xiang Zhang, PhD, Baylor College of Medicine: “The Evolving Cancer-Niche Interactions During Bone Metastasis”